SERA PROGNOSTICS, INC.
Company Information
Industry
Services-Medical Laboratories
SIC Code
8071
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
2749 E. PARLEYS WAY, SALT LAKE CITY, UT, 84109
Mailing Address
2749 E. PARLEYS WAY, SALT LAKE CITY, UT, 84109
Phone
(801) 990-0520
Fiscal Year End
1231
EIN
261911522
Financial Overview
FY2025
$101.93M
Total Assets
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 18, 2026 | View on SEC |
| 10-K Annual financial report | March 18, 2026 | View on SEC |
| 424B5 Prospectus supplement | March 18, 2026 | View on SEC |
| 4 Insider stock transaction report | March 13, 2026 | View on SEC |
| 4 Insider stock transaction report | March 13, 2026 | View on SEC |
| 4 Insider stock transaction report | March 13, 2026 | View on SEC |
| 4 Insider stock transaction report | March 13, 2026 | View on SEC |
| 4 Insider stock transaction report | March 13, 2026 | View on SEC |
| 4 Insider stock transaction report | March 12, 2026 | View on SEC |
| 4 Insider stock transaction report | March 12, 2026 | View on SEC |
Annual Reports
10-K
March 18, 2026
- 35% revenue growth to $5.2 million, indicating early market penetration for its PreTRM test.
- Flagship PreTRM test is gaining increased clinical adoption and payer coverage, with a goal to become the standard of care for preterm birth risk assessment.
Insider Trading
SELL
8 insiders
29 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 8071)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.